We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Speaker: Dr. Paul Hofman, Director of the Institut Hospitalo-Universitaire (IHU) RespirERA - Professor of Pathology at the University Côte d’Azur, Nice - France.
Thoracic pathology has changed dramatically in recent years. Although the microscopic assessment of tissues and cells is and will remain the mainstay of lung cancer diagnosis, molecular profiling has become equally relevant. Thus, to stay abreast of the evolving landscape of today's anatomic pathology, modern thoracic pathologists must be able to master the intricate world of predictive molecular pathology using both tissue and liquid biopsies. To this aim, thoracic pathologists have had to acquire additional knowledge to bridge the gap between clinicians and molecular biologists. This new role is particularly important, as cases are now collegially discussed in molecular tumor boards (MTBs). Moreover, as opposed to « traditional » pathologists, « modern » pathologists have also adamantly embraced innovation while keeping a constant eye on tradition. Current pathology practice is being shaped by the increasing complexity of modern medicine and major technological advances. So, in the “next-generation sequencing era” the thoracic pathologist has become the clinician responsible for the integration and interpretation of morphologic and molecular information and for the delivery of critical answers to lung cancer diagnostic, prognostic and predictive queries, acquiring a prominent position in the personalized medicine scenario, especially in lung cancer care.The presentation attemps to demonstrate the evolutionary role of thoracic pathologists for better treatment decision making, but integrating new tools such as NGS in both tissue and liquid biopsie, as well as the new coming revolution of computational digital pathology in lung cancer.
Host: Dr. Santiago Ramon y Cajal Agüeras, Head of group Translational Molecular Pathology, Vall d'Hebron Research Institute (VHIR).
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.